Chronic critical limb ischemia: European experiences

Journal of Cardiovascular Surgery

Volumn 50, Issue 5, 2009, Pages 647-653

  Diehm, N ^a,d   Silvestro, A ^b   Baumgartner, I ^a   Do, D D ^a   Diehm, C ^c   Schmidli, J ^d   Dick, F ^d  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b BOLOGNINI HOSPITAL   (Italy)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Endovascular surgical procedures; Ischemia; Leg; Limb; Stents

Indexed keywords

ANGIOGENIC FACTOR; ANTITHROMBOCYTIC AGENT; ILOPROST; NV1FGF; PLACEBO; PROSTAGLANDIN DERIVATIVE; RAPAMYCIN; UNCLASSIFIED DRUG;

ANALGESIA; ANGIOGENESIS; ARTERY BYPASS; BALLOON DILATATION; BARE METAL STENT; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; GAUZE DRESSING; GENE TRANSFER; HEART INFARCTION; HUMAN; KIDNEY DISEASE; LEG REVASCULARIZATION; LIMB AMPUTATION; LIMB ISCHEMIA; LIMB PAIN; NEOPLASM; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RETINOPATHY; REVIEW; SECONDARY PREVENTION; STENT; STROKE; ULCER HEALING; VACUUM ASSISTED CLOSURE; WOUND CARE; WOUND CLOSURE;

ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; CRITICAL ILLNESS; EUROPE; GENE THERAPY; HUMANS; ISCHEMIA; LOWER EXTREMITY; PROSTHESIS DESIGN; SECONDARY PREVENTION; STENTS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES; WOUND HEALING;

EID: 70949094298     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 2000;31:S1-S296.
2. Dick F, Diehm N, Galimanis A, Husmann M, Schmidli J, Baumgartner I. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg 2007;45:751-761 (Pubitemid 46483943)
3. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925-1934.
4. Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004;172:95-105.
5. Faglia E, Manuela M, Antonella Q, Michela G, Vincenzo C, Maurizio C et al. Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. Am Heart J 2005;149:e1-6.
6. Faglia E, Clerici G, Caminiti M, Quarantiello A, Curci V, Morabito A. Advantages of myocardial revascularization after admission for critical limb ischemia in diabetic patients with coronary artery disease: data of a cohort of 564 consecutive patients. J Cardiovasc Med (Hagerstown) 2008;9:1030-1036
7. Beard JD. Which is the best revascularization for critical limb ischemia: Endovascular or open surgery? J Vasc Surg 2008;48:11S-6S.
8. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45:S5-S67. (Pubitemid 46151680)
9. Graziani L, Silvestro A, Bertone V, Manara E, Andreini R, Sigala A et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 2007;33:453-460
10. Laird JR. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 2006;13 Suppl 2:II30-40.
11. Kasapis C, Henke PK, Chetcuti SJ, Koenig GC, Rectenwald JE, Krishnamurthy VN et al. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J 2009;30:44-55.
12. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-1888
13. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115:2745-2749
14. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 2006;13:701-710 (Pubitemid 44907633)
15. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008;118:1358-1365
16. Zeller T, Rastan A, Sixt S, Schwarzwalder U, Schwarz T, Frank U et al. Long-term results after directional atherectomy of femoropopliteal lesions. J Am Coll Cardiol 2006;48:1573-1578 (Pubitemid 44528188)
17. Diehm N, Shang A, Silvestro A, Do DD, Dick F, Schmidli J et al. Association of Cardiovascular Risk Factors with Pattern of Lower Limb Atherosclerosis in 2659 Patients Undergoing Angioplasty. Eur J Vasc Endovasc Surg 2006;31:59-63. (Pubitemid 43024985)
18. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007;49:1600-1606
19. Faglia E, Clerici G, Clerissi J, Mantero M, Caminiti M, Quarantiello A et al. When is a technically successful peripheral angioplasty effective in preventing above-the-ankle amputation in diabetic patients with critical limb ischaemia? Diabet Med 2007;24: 823-829
20. Graziani L, Silvestro A, Monge L, Boffano GM, Kokaly F, Casadidio I et al. Transluminal angioplasty of peroneal artery branches in diabetics: initial technical experience. Cardiovasc Intervent Radiol 2008;31:49-55.
21. Ferraresi R, Centola M, Ferlini M, Da Ros R, Caravaggi C, Assaloni R et al. Long-term outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia. Eur J Vasc Endovasc Surg 2009;37:336-342
22. Bosiers M, Lioupis C, Deloose K, Verbist J, Peeters P. Two-year outcome after Xpert stent implantation for treating below the knee lesions in critical limb ischemia. Vascular 2009;17:1-8.
23. Rosales OR, Mathewkutty S, Gnaim C. Drug eluting stents for below the knee lesions in patients with critical limb ischemia: long-term follow-up. Catheter Cardiovasc Interv 2008;72:112-115 (Pubitemid 352008995)
24. Siablis D, Karnabatidis D, Katsanos K, Kagadis GC, Kraniotis P, Diamantopoulos A et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther 2007;14:241-250 (Pubitemid 46776123)
25. Plecha FR, Bertin VJ, Plecha EJ, Avellone JC, Farrell CJ, Hertzer NR et al. The early results of vascular surgery in patients 75 years of age and older: an analysis of 3259 cases. J Vasc Surg 1985;2:769-74.
26. Brosi P, Dick F, Do DD, Schmidli J, Baumgartner I, Diehm N. Revascularization for chronic critical lower limb ischemia in ortogenarians is worthwhile. J Vasc Surg 2007;46:1198-1207